What Are the Latest Guidelines for Colorectal Cancer Screening?

Published: Jan 16, 2024

Staying updated with the latest screening guidelines is crucial for effective colorectal cancer prevention.
Contents

When to Start and Stop Screening

Current guidelines recommend starting colorectal cancer screening at age 45 for those at average risk. Screening should continue until age 75, provided the patient has a life expectancy of at least 10 more years. After 75, the decision to continue screening should be individualized based on health status and prior screening history.

Types of Recommended Tests

The guidelines endorse several tests, including colonoscopy every 10 years, annual FIT, and multitarget stool DNA tests every 1 to 3 years. Each test has its own frequency and detection capabilities, so the choice often depends on patient preference and access.
Current guidelines recommend starting colorectal cancer screening at age 45 for average-risk individuals, with various test options available.

Importance of Follow-Up

Following up on abnormal screening results is vital. Any positive test, other than a colonoscopy, requires a timely follow-up colonoscopy to assess the entire colon. This step is crucial to ensure any potential issues are addressed before they develop further.

Frequently Asked Questions

Screening should start at age 45 for average-risk individuals.

Colonoscopy, annual FIT, and multitarget stool DNA tests.

It ensures potential issues are thoroughly evaluated.

At age 75, unless individual health factors suggest otherwise.

The Big Picture

Adhering to screening guidelines is a crucial step in preventing colorectal cancer.
Consult Doctronic to ensure you're following the latest screening guidelines for colorectal cancer.

Related Articles

References

  1. US Preventive Services Task Force, Davidson KW, Mangione CM, et al. Collaboration and Shared Decision-Making Between Patients and Clinicians in Preventive Health Care Decisions and US Preventive Services Task Force Recommendations. JAMA 2022; 327:1171.
  2. Doubeni CA, et al. Development and evaluation of safety and effectiveness of novel cancer screening tests for routine clinical use with applications to multicancer detection technologies. Cancer 2022; 128 Suppl 4:883.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely
Smiling doctor on a call with a patient
    πŸ˜€ πŸ˜€ πŸ˜€ πŸ˜€ πŸ˜€

Video Call with a
Human Doctor

Quick, affordable video consultations with licensed U.S. Doctors

  • Check mark Diagnosis, prescriptions, referrals & more
  • Check mark 5,000+ Top Licensed U.S. Doctors
  • Check mark Available in all 50 states
Immediate appointments available
Insurance or $39 self-pay πŸ‡ΊπŸ‡Έ Available to U.S. customers only